BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7286886)

  • 1. Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
    Woodhouse NJ; Khouqueer F; Sieck JO
    Horm Res; 1981; 14(3):141-7. PubMed ID: 7286886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine reduction of prolactinoma size.
    Corenblum B; Hanley DA
    Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
    Kahn SE; Miller JL
    S Afr Med J; 1982 Oct; 62(19):696-9. PubMed ID: 7135127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
    J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective management of a suprasellar extending prolactinoma during pregnancy.
    Pittini L; Minisci N; Negri P
    Clin Exp Obstet Gynecol; 1987; 14(3-4):152-4. PubMed ID: 3454722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 16 year old boy with poor vision and nasal obstruction.
    Cook RJ; Besser M
    Aust N Z J Surg; 1987 Jul; 57(7):485-8. PubMed ID: 3475065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
    Scherrer H; Turpin G; De Gennes JL; Schaison-Cusin M; Heshmati HM; Thibierge M; Metzger J
    Ann Med Interne (Paris); 1985; 136(6):459-66. PubMed ID: 4083636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
    Bergh T; Nillius SJ; Enoksson P; Wide L
    J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
    Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
    J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
    Grimson BS; Bowman ZL
    Arch Ophthalmol; 1983 Apr; 101(4):604-6. PubMed ID: 6838419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine treatment of prolactinomas.
    Aronoff SL; Daughaday WH; Laws ER
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440366
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
    Halperin I; Rodriguez MD; Cardenal C; Casamitjana R; Martinez Osaba MJ; Lienas V; Vilardell E
    J Endocrinol Invest; 1987 Jun; 10(3):277-82. PubMed ID: 3040850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
    Robbins RJ; Kern PA; Thompson TL
    Am J Med; 1984 May; 76(5):921-3. PubMed ID: 6720732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiological control of prolactin adenomas treated with bromocriptine].
    Metzger J; Gardeur D; Pehuet M; Houlbert D
    Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
    Schettini G; Lombardi G; Merola B; Miletto P; Fariello C; Cirillo S; Fusco R; Lancranjan I
    J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
    Abs R; Parizel PM; Beckers A
    J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.